Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Systematic Review

Accepted on 22 Aug 2025

The potential value of quercetin for colorectal cancer: A systematic review and a meta-analysis of preclinical studies

in Pharmacology of Anti-Cancer Drugs

Xiucheng Duan
Liyuan Zhang
Fenye Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1642957

Original Research

Published on 22 Aug 2025

8-Nitrotryptanthrin inhibits colorectal cancer progression via TGF-β/SMAD and PI3K/AKT/mTOR pathways

in Pharmacology of Anti-Cancer Drugs

Cheng-Yu Sun
Kai-Ping Cong
Dan-Dan Zhao
En-Guo Fan
Ming-Quan Guo
Zheng-Guo Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1576673

375 views

Review

Accepted on 21 Aug 2025

Targeting Digestive System Cancers with Isoliquiritigenin: A Comprehensive Review of Antitumor Mechanisms

in Pharmacology of Anti-Cancer Drugs

Zhichun Li
Ruohan Feng
Jinze Li
Jinglu Bai
Nuo Li
Zhenhua Cui
Xiaobin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1649472

Original Research

Accepted on 21 Aug 2025

Constructing Scissor+ risk model to predict prognosis and immunotherapy responses in PAAD by integrating bulk and single-cell RNA sequencing data

in Pharmacology of Anti-Cancer Drugs

Gaofei Zhang
Jiao Yu
Fan Zhang
Fang Wang
Congya Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1646840

Original Research

Published on 21 Aug 2025

Model-based prediction of nanoparticle and dissolved form ratios using total concentration data: a case study of SNB-101

in Pharmacology of Anti-Cancer Drugs

Jinha Park
Soo Hyeon Bae
Sangil Jeon
Young Hwan Park
Dong Cheol Lee
Seunghoon Han

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556618

313 views

Review

Accepted on 20 Aug 2025

Cantharidin: A Double-Edged Sword in Medicine and Toxicology

in Pharmacology of Anti-Cancer Drugs

Jie Zhang
Tongtong Tian
Canyu Li
Yong Liu
Yunyun Wang
Ling Liu
Liang Liu
Yufeng Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1644186

Review

Published on 20 Aug 2025

Multimodal integration strategies for clinical application in oncology

in Pharmacology of Anti-Cancer Drugs

Baoyi Zhang
Zhuoya Wan
Yige Luo
Xi Zhao
Josue Samayoa
Weilong Zhao
Si Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1609079

549 views

Original Research

Accepted on 19 Aug 2025

In Silico Repurposing of FDA-Approved Drugs Against MEK1: Structural and Dynamic Insights into lung Cancer Therapeutics

in Pharmacology of Anti-Cancer Drugs

Anas Shamsi
Mohd Shahnawaz Khan
Azna Zuberi
Moyad Shahwan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1619639

148 views

Review

Published on 18 Aug 2025

Antitumor effects and mechanisms of traditional Chinese medicine gamboge: A review

in Pharmacology of Anti-Cancer Drugs

Yanqing Zhou
Jialing Chen
Qin Zhu
Binyan Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1650560

301 views

Original Research

Published on 15 Aug 2025

Real-world study on adverse drug reactions of pembrolizumab in endometrial cancer treatment: insights from the FAERS database

in Pharmacology of Anti-Cancer Drugs

Huiping Zhang
Man Di
Jingjing Wang
Shan Wang
Yini Dai
Jingjing Huang
Zhuo Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1622339

592 views

Brief Research Report

Published on 15 Aug 2025

MYC target gene activation in chronic lymphocytic leukemia and richter transformation: links to aggressiveness and tumor microenvironment interactions

in Pharmacology of Anti-Cancer Drugs

M. Tsagiopoulou
S. Rashmi
M. Chatziaslani
I. Gut

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1642458

580 views

Original Research

Published on 15 Aug 2025

2H-1,4-Benzoxazin-3(4H)-one linked 1,2,3-triazole derivatives and their study on inducing DNA damage in tumor cells

in Pharmacology of Anti-Cancer Drugs

Xixi Hou
Yajie Guo
Xi Wang
En Gao
Jianxue Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564090

840 views

Original Research

Published on 15 Aug 2025

Identification of biomarkers based on ubiquitin-correlated genes for predicting immune profile and drug sensitivity in lung adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Yue Li
Wei Tian
Chen Chen
Hailin Liu
Zhenfa Zhang
Changli Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1646396

371 views

Mini Review

Published on 14 Aug 2025

Drug-tolerant persister cell in cancer: reversibility, microenvironmental interplay, and therapeutic strategies

in Pharmacology of Anti-Cancer Drugs

Haifeng Li
Wenlong Xu
Wenqi Cheng
Guanxiao Yu
Dongmei Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1612089

489 views

Original Research

Published on 14 Aug 2025

FGFC1 overcomes Ara-C resistance in acute myeloid leukemia by inducing apoptosis and pyroptosis

in Pharmacology of Anti-Cancer Drugs

Xiaohui Hu
Zhijian Li
Rui Zhou
Bing Zhang
Ruoxian Wang
Tongtong Li
Jiangcheng Chang
Wenhui Wu
Ning Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584376

467 views

Systematic Review

Published on 14 Aug 2025

Comparative analysis of first-generation epidermal growth factor receptor inhibitors combined with chemotherapy versus third-generation epidermal growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Siyan Peng
Zhixin Yu
Honglin Zhu
Chuwen Liang
Huijuan Qiu
Shaodong Hong
Yixin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586332

393 views